5AM Opportunities I (GP), LLC: insider trades.
5AM Opportunities I (GP), LLC reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($1.2M), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- 5AM Opportunities I (GP), LLC
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | TenPercentOwner | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-07 | Entrada Therapeutics, Inc. | S | 52,317 | $6.85 | 2,783,781 | Form 4 |
| 2026-08-06 | Entrada Therapeutics, Inc. | S | 10,494 | $7 | 2,836,098 | Form 4 |
| 2026-07-31 | Entrada Therapeutics, Inc. | S | 1,718 | $6.85 | 2,846,592 | Form 4 |
| 2026-07-30 | Entrada Therapeutics, Inc. | S | 114,756 | $6.93 | 2,848,310 | Form 4 |
Questions
What stock did 5AM Opportunities I (GP), LLC buy or sell?
5AM Opportunities I (GP), LLC reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($1.2M), across 1 company.
Is 5AM Opportunities I (GP), LLC the same person as other filers with this name?
This page covers SEC CIK 1790778 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/5am-opportunities-i-gp-llc-1790778.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.